Dr Reddy’s Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules, used for treatment of frequent heartburn, in the US market.
The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food and Drug Administration, Dr Reddy’s said in a BSE filing. Last week, Dr Reddy’s had announced the launch of Fosaprepitant for injection in the US.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.